News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Enveric Biosciences Announces Successful Synthesis and Filing of Provisional Patent for EV104 – Cannabinoid + Celecoxib Conjugate
Enveric Biosciences
MYND Diagnostics Inc. Announces Participation in Approved Monash University (Australia) Government Funded $3 Million Clinical Trial
MYND Diagnostics
Clearmind Medicine Secures CAD$1.6 Million in Private Placement
Clearmind Medicine
Mydecine’s Exclusive Dealer Identified as Licensed Psilocybin and MDMA Supplier in Canada
Mydecine Innovations Group
Matthew Singh | CCO, Psyched Wellness
Psyched Wellness
Tryp Therapeutics Announces $2,000,000 Financing and Changes in Management, Board of Directors
Tryp Therapeutics
Algernon Pharmaceuticals Announces Completion of Enrollment in its Phase 2 Study of Ifenprodil for IPF and Chronic Cough
Algernon Pharmaceuticals
Entheon Biomedical Announces the Approval of DMT Clinical Trial
Entheon Biomedical
Blackhawk Publishes MindBio Therapeutics Investor Presentation & Q&A Event on Website
MindBio Therapeutics
Psyched Wellness Announces Additional Positive Results from the 14-day Oral Toxicity Study of AME-1
Psyched Wellness
Universal Ibogaine Commences Development Plan at Kelburn in Preparation for Ibogaine Treatments and Provides Update on Drug Supply
Universal Ibogaine
Wellbeing Digital Sciences Reveals Recent Achievement By Its KGK Science Subsidiary
Wellbeing Digital Sciences
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.